Orthofix is discontinuing its M6-C and M6-L total disc replacement devices as part of its strategic focus on spinal and deformity correction, the company said Feb. 25.
Global sales for the cervical and lumbar disc replacement devices were $23.4 million, according to a news release. Resources associated with the discs will be allocated to “more profitable growth opportunities.”
Orthofix will still fulfill requirements related to post-market surveillance activities and completion of an Investigational Device Exemption study in the U.S.
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will…
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its…
Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus…